Achieve Life Sciences, Inc. (ACHV) — 10-K Filings
All 10-K filings from Achieve Life Sciences, Inc.. Browse 3 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (3)
-
Achieve Life Sciences Nears FDA Decision for Smoking Cessation Drug
— Mar 24, 2026 Risk: high
Achieve Life Sciences, Inc. (ACHV) is a late-stage clinical specialty pharmaceutical company focused on developing cytisinicline for nicotine dependence. The co -
Achieve Life Sciences Files 2024 Annual Report
— Mar 11, 2025 Risk: medium
Achieve Life Sciences, Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company, formerly known as OncoGenex Pharmaceuticals, Inc. and Sonu -
Achieve Life Sciences Files 2023 Annual Report on Form 10-K
— Mar 28, 2024 Risk: low
ACHIEVE LIFE SCIENCES, INC. (ACHV) filed a Annual Report (10-K) with the SEC on March 28, 2024. Achieve Life Sciences, Inc. filed its 2023 Form 10-K on March 28
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX